Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance®): A New Treatment for the Management of Type 2 Diabetes Mellitus

Author： Jaime A. Davidson  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.27, Iss.15, 2004-01, pp. : 1205-1216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glibenclamide plus metformin combination tablets are effective, convenient and well tolerated in the treatment of type 2 diabetes mellitus

By Derosa Giuseppe  

Drugs & Therapy Perspectives, Vol. 22, Iss. 8, 2006-08 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

By Lamos Elizabeth Mary   Stein Stephanie Aleskow   Davis Stephen N  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2545-2554

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Glyburide/Metformin Tablets (Glucovance™) versus Equivalent Doses of Glyburide and Metformin in Patients with Type 2 Diabetes

By Donahue S.R.   Turner K.C.   Patel S.  

Clinical Pharmacokinetics, Vol. 41, Iss. 15, 2002-01 ,pp. : 1301-1309

Adis International

Access to resources Recommend Favorite

Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes

By Dailey George E  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1417-1430

Informa Healthcare

Access to resources Recommend Favorite

The French launch of the type 2 diabetes mellitus combination treatment rosiglitazone/metformin [Avandamet] has been announced

By  

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite